Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00946010
NCT00946010CompletedNot Applicable

Investigation of Hepatitis B and Hepatitis C in Taiwan

National Taiwan University Hospital1 site in 1 country6,228 target enrollmentStarted: April 2008Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
6,228
Locations
1
Primary Endpoint
genotype and DNA level or RNA level of HBV and HCV virus
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.

Detailed Description

The purpose of this study is investigating the differences of genotypes and DNA level or RNA level of hepatitis B and hepatitis C in Taiwan.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
23 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Born before 1985/01/01
  • •HBV or HCV carriers

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

genotype and DNA level or RNA level of HBV and HCV virus

Time Frame: once during Mar. 2008- Jan. 2011

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old ChildrenHepatitis B
NCT04294433Laval University431
Completed
Not Applicable
Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope GlycoproteinsHepatitis C
NCT02574884University Hospital, Tours8
Unknown
Not Applicable
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker DiversityHepatitis B, ChronicEnd Stage Liver DiseaseCarcinoma, HepatocellularHepatitis B
NCT02148562Universitaire Ziekenhuizen KU Leuven274
Active, not recruiting
Not Applicable
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir PlusTenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study.Revised Protocol 01, incorporating protocol amendment 02 (Version 2.0, Date 22-Jan-07). - The BE-LOW Study
EUCTR2006-000421-62-GRBristol-Myers Squibb International Corporation462
Active, not recruiting
Not Applicable
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir Plus Tenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study - The BE-LOW StudyCHRONIC HEPATITIS B VIRUS,TREATMENT-NAIVMedDRA version: 6.1Level: PTClassification code 10019731
EUCTR2006-000421-62-ITBristol-Myers Squibb International Corporation462